These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 23574774)
1. Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"? Netto GJ Adv Anat Pathol; 2013 May; 20(3):175-203. PubMed ID: 23574774 [TBL] [Abstract][Full Text] [Related]
2. The role of imaging in the surveillance of urologic malignancies. Bradford TJ; Montie JE; Hafez KS Urol Clin North Am; 2006 Aug; 33(3):377-96. PubMed ID: 16829272 [TBL] [Abstract][Full Text] [Related]
3. [Tumor markers in urological malignancies]. Kuriyama M Nihon Rinsho; 1996 Jun; 54(6):1631-6. PubMed ID: 8691621 [TBL] [Abstract][Full Text] [Related]
9. The role of methylation in urological tumours. van der Heijden AG Arch Esp Urol; 2013 Jun; 66(5):432-9. PubMed ID: 23793761 [TBL] [Abstract][Full Text] [Related]
10. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449 [TBL] [Abstract][Full Text] [Related]
11. [Advances in urologic oncology]. Boccon-Gibod L Prog Urol; 1991 Feb; 1(1):17-21. PubMed ID: 1364643 [No Abstract] [Full Text] [Related]
12. Urine microRNAs as potential noninvasive biomarkers in urologic cancers. Mlcochova H; Hezova R; Stanik M; Slaby O Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473 [TBL] [Abstract][Full Text] [Related]
13. Tumor markers in urologic cancer. Javadpour N Urology; 1980 Aug; 16(2):127-36. PubMed ID: 6157242 [No Abstract] [Full Text] [Related]
15. Prognosis of genito-urinary malignancies. Cos LR; Caldamone AA; Frank IN AUAA J; 1982; 3(1):4-8. PubMed ID: 6226266 [No Abstract] [Full Text] [Related]
16. Next-generation sequencing of urologic cancers: next is now. Real FX; Boutros PC; Malats N Eur Urol; 2014 Jul; 66(1):4-7. PubMed ID: 24731787 [TBL] [Abstract][Full Text] [Related]
17. [Significance of current bio- and molecular-markers in urological cancers]. Shimazui T; Akaza H Gan To Kagaku Ryoho; 2004 Jul; 31(7):1008-14. PubMed ID: 15272577 [TBL] [Abstract][Full Text] [Related]
18. Theranostic and prognostic biomarkers: genomic applications in urological malignancies. Netto GJ; Epstein JI Pathology; 2010 Jun; 42(4):384-94. PubMed ID: 20438413 [TBL] [Abstract][Full Text] [Related]